Joseph Shulman

Director Técnico/Científico/I+D en RHYTHM PHARMACEUTICALS, INC. .

Fortuna: 1 145 $ al 30/04/2024

49 años

Health Technology

Consumer Services

Cargos activos de Joseph Shulman

Empresas	Cargo	Inicio	Fin
RHYTHM PHARMACEUTICALS, INC.	Director Técnico/Científico/I+D	27/07/2020	-

Empresas	Cargo	Inicio	Fin
RA PHARMACEUTICALS, INC.	Director Técnico/Científico/I+D	01/07/2019	01/07/2020
NOVELION THERAPEUTICS INC.	Director Técnico/Científico/I+D	01/09/2014	01/07/2019

Boston University	Masters Business Admin
University of Miami	Undergraduate Degree

Internacional

Operativa

Sectorial

Health Technology	4
Consumer Services	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
RHYTHM PHARMACEUTICALS, INC.	Health Technology

Empresas privadas	2
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology
Novelion Therapeutics, Inc. Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada.	Health Technology

Empresas privadas

Health Technology